Improving outcomes for brain metastases in EGFR mutated NSCLC

類似資料

• EGFR-TKI plus brain radiotherapy versus EGFR-TKI alone in the management of EGFR-mutated NSCLC patients with brain metastases
  著者:: Dong, Kai, 等
  出版事項: (2019)
• Prognostic significance of EGFR and KRAS mutations in NSCLC patients with brain metastases treated with radiosurgery(†)
  著者:: Parikh, Neil R., 等
  出版事項: (2015)
• Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
  著者:: Tan, Wan-Ling, 等
  出版事項: (2018)
• LDA-SVM-Based EGFR Mutation Model for NSCLC Brain Metastases: An Observational Study
  著者:: Hu, Nan, 等
  出版事項: (2015)
• Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
  著者:: Tan, Wan-Ling, 等
  出版事項: (2018)